IDH1 and IDH2 Mutation Analysis

View Test

IGH/BCL2 t(14;18) FISH

  • Test Code:
    7360 7361 FFPE
  • Department:
  • Test Synonyms:
    Follicular Lymphoma
View Test

IGH/CCND1 t(11;14) FISH

  • Test Code:
    7090 7091 FFPE
  • Department:
  • Test Synonyms:
    Mantle Cell Lymphoma
View Test

IL28B Genotyping for Patients with HCV-1

  • Test Code:
    4670
  • Department:
  • Test Synonyms:
    Interleukin 28B polymorphism IL28B gene variation
View Test

Infantile Epilepsy Panel

  • Test Code:
    1675
  • Department:
  • Test Synonyms:
    West Syndrome ADSL ALDH5A1 ALDH7A1 AMT ARX BTD CDKL5 CLN3 CLN5 CLN6 CLN8 CNTNAP2 CTSD FOLR1 FOXG1 GABRG2 GAMT GCH1 GLDC GRIN2A KCNJ10 KCNQ2 KCNQ3 KCTD7 LIAS MAGI2 MBD5 MECP2 MEF2C MFSD8 MMACHC MTHFR NRXN1 PCBD1 PHGDH PNKP PNPO POLG PPT1 PRRT2 PTS QDPR SCN1A SCN1B SCN2A SCN8A SLC25A22 SLC2A1 SLC6A8 SLC9A6 SPTAN1 STXBP1 TBC1D24 TCF4 TPP1 TSC1 TSC2 UBE3A WDR45 ZEB2
View Test

Infantile Neuroaxonal Dystrophy, PLA2G6, Deletion/Duplication

  • Test Code:
    1681
  • Department:
  • Test Synonyms:
    INAD PLA2G6-Related Infantile Neuroaxonal Dystrophy Seitelberger Disease NBIA PLAN Atypical NAD Dystonia-parkinsonism
View Test

Infantile Neuroaxonal Dystrophy, PLA2G6, Sequencing

  • Test Code:
    1682
  • Department:
  • Test Synonyms:
    INAD PLA2G6-Related Infantile Neuroaxonal Dystrophy Seitelberger Disease NBIA PLAN Atypical NAD Dystonia-parkinsonism
View Test

Infantile Neuroaxonal Dystrophy, PLA2G6, Sequencing and Deletion/Duplication

  • Test Code:
    1680
  • Department:
  • Test Synonyms:
    INAD PLA2G6-Related Infantile Neuroaxonal Dystrophy Seitelberger Disease NBIA PLAN Atypical NAD Dystonia-parkinsonism
View Test

Inherited Breast Cancer Panel

View Test

Inherited Cancer Panel

  • Test Code:
    2025
  • Department:
  • Test Synonyms:
    Familial Cancer Hereditary Cancer Breast Cancer Ovarian Cancer Endometrial Cancer Colon Cancer Colorectal cancer Lynch Syndrome Renal Cancer Pancreatic Cancer Multiple Endocrine Neoplasia Melanoma Birt-Hogg-Dube Bloom Carney Complex Gorlin Syndrome APC ATM BAP1 BARD1 BLM BMPR1A BRCA1 BRCA2 BRIP1 CDC73 CDH1 CDK4 CDKN1B CDKN2A CHEK2 EPCAM FH FLCN MAX MEN1 MET MITF MLH1 MRE11A MSH2 MSH6 MUTYH NBN NF1 PALB2 PMS2 PRKAR1A PTCH1 PTEN RAD50 RAD51C RAD51D RB1 RET SDHA SDHAF2 SDHB SDHC SDHD SMAD4 STK11 TMEM127 TP53 TSC1 TSC2 VHL XRCC2
View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More